Martyn E. Caplin | Authors


Efficacy of Lanreotide for the Treatment of Neuroendocrine Tumors

October 17, 2015

Martyn E. Caplin, professor, lead clinician, Neuroendocrine Unit at the Royal Free Hospital, London, discusses the efficacy of lanreotide for the treatment of patients with neuroendocrine tumors, as shown in clinical trials such as the CLARINET study.